DexCom (DXCM.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec1

FDA Warns DexCom Over Unauthorized Design Changes in Glucose Monitors

12:55

Nov28

Rockefeller Capital Management Buys Shares of DexCom in Q2

10:29

Nov27

Rhenman & Partners Increased Holdings in DexCom

12:27

Nov24

Oppenheimer Downgrades DexCom Inc. Rating and Removes Price Target

14:03

Nov21

Eagle Health Investments LP reduces holdings in DexCom

09:49

Nov20

DexCom Launches Dexcom G7 15-Day Continuous Glucose Monitoring System

13:31

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.209 B, Net Income 283.8 M, EPS 0.7034

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.157 B, Net Income 179.8 M, EPS 0.4475

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.036 B, Net Income 105.4 M, EPS 0.2657

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change